Kimby E - Search Results

1

T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab.

Wahlin BE, Sundström C, Holte H, Hagberg H, Erlanson M, Nilsson-Ehle H, Lindén O, Nordström M, Ostenstad B, Geisler CH, Brown Pde N, Lehtinen T, Maisenhölder M, Tierens AM, Sander B, Christensson B, Kimby E. Wahlin BE, et al. Among authors: kimby e. Clin Cancer Res. 2011 Jun 15;17(12):4136-44. doi: 10.1158/1078-0432.CCR-11-0264. Epub 2011 Apr 25. Clin Cancer Res. 2011. PMID: 21518780 Free article.

2

Beyond immunochemotherapy: combinations of rituximab with cytokines interferon-alpha2a and granulocyte colony stimulating factor [corrected].

Kimby E. Kimby E. Semin Oncol. 2002 Apr;29(2 Suppl 6):7-10. doi: 10.1053/sonc.2002.32747. Semin Oncol. 2002. PMID: 12040528 Review.

3

Rituximab therapy for indolent non-Hodgkin's lymphoma.

Hagenbeek A, Czuczman MS, Ghielmini M, Herold M, Kimby E, Solal-Céligny P, Unterhalt M. Hagenbeek A, et al. Among authors: kimby e. Anticancer Drugs. 2002 Nov;13 Suppl 2:S11-7. Anticancer Drugs. 2002. PMID: 12710586 Review.

4

Safety of rituximab therapy during the first trimester of pregnancy: a case history.

Kimby E, Sverrisdottir A, Elinder G. Kimby E, et al. Eur J Haematol. 2004 Apr;72(4):292-5. doi: 10.1111/j.1600-0609.2004.00214.x. Eur J Haematol. 2004. PMID: 15089769

5

Posttransplant lymphoma--a single-center experience of 500 liver transplantations.

Norin S, Kimby E, Ericzon BG, Christensson B, Sander B, Söderdahl G, Hägglund H. Norin S, et al. Among authors: kimby e. Med Oncol. 2004;21(3):273-84. doi: 10.1385/MO:21:3:273. Med Oncol. 2004. PMID: 15456956

6

Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.

Sander B, Flygare J, Porwit-Macdonald A, Smith CI, Emanuelsson E, Kimby E, Liden J, Christensson B. Sander B, et al. Among authors: kimby e. Int J Cancer. 2005 Nov 10;117(3):418-30. doi: 10.1002/ijc.21166. Int J Cancer. 2005. PMID: 15900590 Free article.

7

Tolerability and safety of rituximab (MabThera).

Kimby E. Kimby E. Cancer Treat Rev. 2005 Oct;31(6):456-73. doi: 10.1016/j.ctrv.2005.05.007. Epub 2005 Jul 28. Cancer Treat Rev. 2005. PMID: 16054760 Review.

8

Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.

Flygare J, Gustafsson K, Kimby E, Christensson B, Sander B. Flygare J, et al. Among authors: kimby e. FEBS Lett. 2005 Dec 19;579(30):6885-9. doi: 10.1016/j.febslet.2005.11.020. FEBS Lett. 2005. PMID: 16337199 Free article.

9

Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial.

van Oers MH, Klasa R, Marcus RE, Wolf M, Kimby E, Gascoyne RD, Jack A, Van't Veer M, Vranovsky A, Holte H, van Glabbeke M, Teodorovic I, Rozewicz C, Hagenbeek A. van Oers MH, et al. Among authors: kimby e. Blood. 2006 Nov 15;108(10):3295-301. doi: 10.1182/blood-2006-05-021113. Epub 2006 Jul 27. Blood. 2006. PMID: 16873669 Free article. Clinical Trial.

10

CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.

Wahlin BE, Sander B, Christensson B, Kimby E. Wahlin BE, et al. Among authors: kimby e. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):388-97. doi: 10.1158/1078-0432.CCR-06-1734. Clin Cancer Res. 2007. PMID: 17255259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page